Angiotensin II induction of osteopontin expression and DNA replication in rat arteries

Hypertension

Volumn 28, Issue 6, 1996, Pages 1055-1063

  DeBlois, Denis ^a,b   Lombardi, Donna M ^a   Su, Enming J ^a   Clowes, Alexander W ^a   Schwartz, Stephen M ^a   Giachelli, Cecilia M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

angiotensin II; catecholamines; growth substances; muscle, smooth, vascular; osteopontin; vascular diseases

Indexed keywords

ANGIOTENSIN; BROXURIDINE; CATECHOLAMINE; DNA; MESSENGER RNA; NORADRENALIN; OSTEOPONTIN; PHENYLEPHRINE;

ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; DNA REPLICATION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENOVASCULAR DISEASE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0029852896     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.1055     Document Type: Article

References (49)

1. Giachelli CM, Schwartz SM, Liaw L. Molecular and cellular biology of osteopontin. Trends Cardiovasc Med. 1995;5:88-95.
2. Giachelli CM, Bae N, Lombardi DM, Majesky MW, Schwartz SM. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem Biophys Res Commun. 1991;177:867-873.
3. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
4. O'Brien ER, Garvin MR, Stewart DK, Hinohara T, Simpson JB, Schwartz SM, Giachelli CM. Osteopontin is synthesized by macrophage, smooth muscle and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb. 1994; 14:1648-1656.
5. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993;92:2814-2820.
6. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries: association of osteopontin with atherosclerosis. J Clin Invest. 1994;94:1597-1604.
7. 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995; 95:713-724.
8. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994;74: 214-224.
9. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim H-M, Kitamura Y, Yutani C, Nomura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993;143:1003-1008.
10. Gadeau A-P, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb. 1993;13:120-125.
11. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
12. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall. Circ Res. 1991;68:450-456.
13. 1 receptor expression. Arterioscler Thromb Vasc Biol. 1996;16:1130-1137.
14. Orlandi A, Ehrlich HP, Ropraz P, Spagnoli LG, Gabbiani G. Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro. Arterioscler Thromb. 1994;14:982-989.
15. 1-adrenoreceptor stimulation increases DNA synthesis in rat arterial wall: modulation of responsiveness after vascular injury. Arterioscler Thromb Vasc Biol. 1996;16:1122-1129.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
17. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest. 1988;82:1134-1143.
18. Van Kleef EM, Smits JFM, DeMey JGR, Cleutjens JPM, Lombardi DM, Schwartz SM, Daemen MJAP. Alpha-1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res. 1992;70:1122-1127.
19. Dijkstra CD, Döpp EA, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by the monoclonal antibodies ED-1, ED-2 and ED-3. Immunology. 1985;54:589-599.
20. Han DK, Liau G. Identification and characterization of developmentally regulated genes in vascular smooth muscle cells. Circ Res. 1992;71:711-719.
21. Schwartz SM, deBlois D, O'Brien ER. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
22. Majesky MW, Giachelli CM, Schwartz SM. Rat carotid neointimal smooth muscle cells re-express a developmentally regulated phenotype during repair of arterial injury. Circ Res. 1992;71:759-768.
23. Walker L, Bowen-Pope DF, Ross R, Reidy MA. Production of PDGF-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci U S A. 1986;83:7311-7315.
24. Shaefer HE. Proliferation versus atrophy: the ambivalent role of smooth muscle cells in human atherosclerosis. Basic Res Cardiol. 1994:89(suppl 1):47-58.
25. O'Brien ER, Alpers CE, Ferguson M, Tran N, Stewart DK, Gordon D, Bendit EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue: implications for anti-proliferative therapy. Circ Res. 1993;73:223-231.
26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-813.
27. Aberg G, Ferrer P. Effects of captopril on atherosclerosis in cynomolgus monkeys. J Cardiovasc Pharmacol 1990;15:S65-S72.
28. Chobanian AV, Haudenschild CC, Nickerson C, Drago R. Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990;15:327-331.
29. Kowala MC. Captopril decreases accelerated atherosclerosis in hypertensive one kidney one clip rats fed cholesterol. Drug Dev Res. 1993;29:100-107.
30. Jacobsson L, Persson K, Aberg G, Andersson RG, Kalberg BE, Olsson AG. Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. J Cardiovasc Pharmacol. 1994;24:670-677.
31. Kowala MC, Grove RI, Aberg G. Inhibitors of the angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters: fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis. 1994;108:61-72.
32. Clozel J-P, Hess P, Schietinger K, Breu V, Fischli W, Baumgartner HR. Major role of the renin-angiotensin system in the neointima formation after vascular injury. Life Sci. 1994;54:PL87-PL92.
33. Shibutani T, Kanda A, Ishigai Y, Mori T, Chiba K, Tanaka M, Tachizawa H. Inhibitory effect of perindopril, a novel angiotensin-converting enzyme inhibitor, on neointima formation after balloon injury in rats and cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1994;24:509-516.
34. Clozel J-P, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension. 1991;18(suppl II): II-55-II-59.
35. Powell J, Clozel J, Muller R, Kuhn H, Hefti F, Hosang M, Baumgartner H. Inhibitors of angiotensin-converting enzyme prevent myo-intimal proliferation after vascular injury. Science. 1989;245:186-188.
36. Wilcox JN. Thrombin and other potential mechanisms underlying restenosis. Circulation. 1991;84:432-435.
37. Huber KC, Schwartz RS, Edwards WD, Camrud AR, Bailey KR, Jorgenson MA, Holmes DR. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J. 1993;125:695-701.
38. Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation. 1994;90:449-455.
39. Rakugi H, Krieger J, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin-converting enzyme in neointima after balloon injury: possible role in restenosis. J Clin Invest. 1994;93:339-346.
40. Fishel RS, Thourani V, Eisenberg SJ, Shai S-Y, Corson MA, Nabel EG, Bernstein KE, Berk BC. Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. J Clin Invest. 1995;95:377-387.
41. Prescott M, Webb R, Reidy MA. Angiotensin-converting enzyme inhibitors versus angiotensin II, AT1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol. 1991;139:1291-1302.
42. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, Giacelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening following endothelial denudation. Arterioscler Thromb Vasc Biol. In press.
43. 3 antagonists promote tumor regression by inducing apoptosis in angiogenic blood vessels. Cell. 1994;79:1157-1164.
44. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H. Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med. 1990;171:1931-1942.
45. Giachelli CM, Pichler R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ. Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 1994;45:515-524.
46. Jonasson L, Holm J, Hansson GK. Smooth muscle cells express Ia antigens during arterial response to injury. Lab Invest. 1988;58: 310-315.
47. Hedin U, Holm H, Hansson GK. Induction of tenascin in rat arterial injury: relationship to altered smooth muscle cell phenotype. Am J Pathol. 1991;139:649-656.
48. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, Weller A, Buhler FR. Expression of tenascin by vascular smooth muscle cells: alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol. 1992;141:377-388.
49. Sharifi BG, LaFleur DW, Pirola CJ, Forrester JS, Fagin JA. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem. 1992;267:23910-23915.